Amendments to allow Gov’t to purchase “innovative” medicines at discounted prices

A new bill will allow the Georgian Government to purchase “innovative” medical drugs at discounted prices, in a bid to improve access to the products for customers, the Government Administration revealed on Monday.

The initiative will introduce the internationally used Managed Entry Agreement system, which involves firms and healthcare payers and enables coverage of new drugs.

The coverage is designed to “manag[e] uncertainty around [the products’] financial impact or performance”, the Organisation for Economic Co-operation and Development says.

The Government Administration said the bill would “positively affect users of innovative original pharmaceutical products, increase access to innovative medicines and improve the efficiency of spending of public funds”.